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Abstract.  The signal requirement for the nuclear im- 
port of U1 RNA in somatic cells from different spe- 
cies was investigated by microinjection of both 
digoxygenin-labeled wild type and mutant U1 RNA 
molecules and in vitro reconstituted U1 snRNPs.  U1 
RNA was shown to be targeted to the nucleus by a 
temperature-dependent process that requires the prior 
assembly of RNPs from the common proteins and the 
microinjected RNA. Competition in the cell between 
immunoaftinity-purified  U1 snRNPs and digoxygenin- 
labeled U1 snRNPs reconstituted in vitro showed that 
the transport is saturable and should therefore be a 
mediated process. The transport of a karyophilic pro- 
tein under the same conditions was not affected, indi- 
cating the existence of a  U snRNP-specific transport 
pathway in somatic cells, as already seen in the Xeno- 
pus/aev/s ooeyte system. Surprisingly,  the signal re- 
quirement for nuclear transport of U1  snRNP was 
found to differ between oocytes and somatic cells from 
mouse, monkey and Xenopus, in that the m3GGpppG- 
cap is no longer an essential signaling component in 
somatic cells. However, as shown by investigation of 
the transport kinetics of m3GpppG-  and ApppG-capped 
U1 snRNPs, the m3GpppG-cap accelerates the rate of 
U1 snRNP import significantly indicating that it has 
retained a  signaling role for nuclear targeting of U1 
snRNP in somatic cells. Moreover, our data strongly 
suggest that cell specific rather than species specific 
differences account for the differential m3G-cap re- 
quirement in nuclear import of U1  snRNPs. 
the nuclear envelope,  continual  exchange of macro- 
molecules between the nucleus and the cytoplasm 
takes place. For large components,  such as proteins, 
RNAs,  and  RNA-protein complexes  (RNPs), t this  trans- 
port is signal mediated and saturable and hence a receptor- 
mediated process. (Feldherr et al.,  1984;  Goldfarb et al., 
1986; Forbes,  1992).  Up to now, the transport of proteins 
into the nucleus is the best understood of these processes 
(reviewed in Garcia-Bustos et al., 1991; Silver, 1991). It oc- 
curs in two separate steps: the initial binding of the protein 
to the nuclear pore complex, followed by an ATP-dependent 
translocation  of the protein into the nucleus (Richardson  et 
al.,  1988; Newmeyer and Forbes, 1988). 
The  information  contained  in  nuclear  location  signals 
(NLS) allows the selective interaction of karyophilic proteins 
with import  receptors (reviewed  in Garcia Bustos et al., 
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1991; Silver,  1991; Nigg et al.,  1991; Forbes, 1992). Some 
nuclear proteins bear signals composed of a single short ba- 
sic sequence resembling the NLS of the SV-40 large T-anti- 
gen (Lanford and Butel, 1984; Lanford et al., 1986; Kalde- 
ron  et  al.,  1984)  while  others  contain  a  more  complex 
bipartite NLS first defined in nucleoplasmin  (Robbins et al., 
1991). 
In addition  to karyophilic  proteins,  RNA-protein com- 
plexes such as the spliceosomal U snRNPs U1, U2, U4, and 
U5 are a further major group of macromolecnles which are 
selectively  targeted to the nucleus. 
The snRNAs U1-U5 are all transcribed by RNA polymer- 
ase II and share two structural  motifs:  the n~GpppG-cap 
structure  (m~O-cap) containing  the  m2.2.7-trimethylguano  - 
sine (Reddy and Busch, 1988) and a single-stranded  uridylic 
acid-rich  sequence referred to as the Sin-binding site (Bran- 
lant et al., 1982; Liautard et al., 1982). Two classes of pro- 
teins bind to the individual snRNAs. One group of common 
(Sin) proteins designated  B, B', D1, D2, D3, E, F, and G are 
present in all U snRNPs (Liihrmann et al., 1990). They bind 
to the Sm site of the snRNA forming  the Sm core domain 
which is morphologically similar among all spliceosomal U 
snRNPs (Kasmer et al., 1990; Liihrmann et al., 1990). The 
second class is comprised of specific proteins which bind 
only to one particular  U snRNA species (Liihrmann  et al., 
1990). 
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export of the nuclear encoded mTG-capped U snRNA to the 
cytoplasm followed by the association of these RNAs with 
the Sm proteins  and hypermethylation of the mTG  - to the 
m3G-cap (DeRobertis, 1983; Mattaj and DeRobertis, 1985; 
Mattaj, 1988). The snRNP particle then returns to the nu- 
cleus. In Xenopus laevis oocytes the nuclear location signal 
of U1 snRNP is bipartite with the m3G-cap as one essential 
signaling component (Fischer and Liihrmann,  1990; Hamm 
and Mattaj, 1990). The second part of the signal is located 
within the Sm core domain but has not yet been precisely 
defined (Fischer et al., 1993). Competition studies revealed 
that U1 snRNP and karyophilic proteins do not compete for 
common transport factors and therefore follow different ki- 
netic  transport  pathways (Michaud  and  Goldfarb,  1991, 
1992; Fischer  et al.,  1993). Surprisingly, not all splieeo- 
somal  snRNAs  have the  same  m3G-cap requirement  for 
nuclear transport  in oocytes. Whereas  U1  and U2 cannot 
enter the nucleus without an intact m3G-cap, this structure 
has a much less pronounced influence on the transport of U4 
and U5. The latter RNAs can enter the nucleus as ApppG- 
capped derivatives, although with reduced transport kinetics 
(Fischer  et al.,  1991). The differential requirement  of the 
m3G-cap for UI and U5 transport  is unlikely to be due to 
differences in the activity of  the Sm core NLS of  both snRNP 
types, since UI and U5 snRNPs compete for the same trans- 
port receptor. Rather the structure of the RNAs appears to 
be important for the requirement for an m3G-cap as an es- 
sential  signaling  component  (Fischer  et  al.,  1993; Jar- 
molowski and Mattaj, 1993). 
In the X./aev/s oocyte, the various snRNA molecules ex- 
hibit different signal requirements for nuclear transport.  It 
may therefore be asked whether the requirements for trans- 
port for the individual snRNAs differ from one cell type to 
another. For karyophilic proteins, several cases have already 
been described where the NLS activity differs between cell 
types or stages of development (Slaviak et al., 1989; Stan- 
diford and Richter,  1992). For example, the adenovirus 5 
EtA protein contains two NLSs, of which one is constitu- 
tively active while the other appears to be regulated during 
embryogenesis of X.  /aev/s (Standiford and Richter, 1992). 
Among snRNAs, it has been reported that in somatic cells 
U2  RNA may be transported  to the nucleus  in an m3G- 
cap-independent  manner after transfection into human 293 
cells  (Kleinschmidt  and Pederson,  1990). However, this 
study left open both the possibility that the transfection pro- 
cedure per se affected the transport process and the alterna- 
tive interpretation that the accumulation in the nucleus of  the 
RNA introduced was due to cell divisions that might have oc- 
curred in the course of their experiments. 
In this report we have studied the nuclear transport of U1 
RNA molecules labeled  with digoxygenin and U1  snRNP 
particles reconstituted in vitro. Both were microinjected into 
living somatic cells from different species. It is shown that 
the transport occurs in a temperature-dependent and satura- 
ble fashion, for which the assembly of  the common proteins 
onto the U1 RNA is an essential prerequisite. The transport 
of U1  snRNP  requires  different limiting transport  factors 
than those required for the transport of  karyophilic proteins. 
The signal required to target the U1  snRNP-particle in so- 
matic cells is shown to consist of the Sm core domain and 
the m3G-cap. However, in contrast to nuclear transport  of 
U1 snRNP in the oocyte, the cap has no essential function, 
but accelerates the transport kinetics significantly. 
Materials and Methods 
In Vitro Transcription 
In vitro transcription of U snRNA genes. The clones XeUI, XeUIAD, and 
pSmII were linearized with BamH1 or in the case of pSmlI with Avai and 
used for in vitro generation of snRNAs.  XeUI and XeU1AD RNAs were 
generated by T7-, and pSmII RNAs by SP6 transcription, respectively.  In 
a typical 100-t~!  transcription assay 10 ~g of linearized DNA template was 
incubated in buffer containing 40 mM Tris-HCi, pH 8.0, 5 mM MgCI2, 2 
mM spermidine, 50 mM NaC1, 25 mM DTE, 0.1/~g//d BSA, 10 mM of 
the indicated cap dinucleotide,  2 mM each of GTP, ATP, and CTP, 1.5 mM 
UTP and 0.5 mM digoxygenin*UTP, and 1 U/~I polymerase.  Transcription 
was allowed to proceed for 90 rain at 370C and stopped hereafter by adding 
1 U//d R2~Ase free DNAse I and continuing the incubation for 15 rain at 
37°C.  RNA was phenul-extracted and precipitated with 3 vol of ethanol. 
Transcription efficiency was analyzed by separation of 2.5/~1 of the tran- 
scription assay in an 0.8% TAE agarose gel and visualizing the bands with 
2 ~tg/mi ethidium bromide.  The typical yield of one transcription reaction 
was between 5 and 30/tg RNA. 
In Vitro Reconstitution of  Digoxygenin-labeled 
U snRNPs 
In vitro reconstitution of U snRNPs was carried out essentially as described 
in Sumpter et al. (1992) with the exception that digoxygenin-laheled  instead 
of 32p-labeled U sn RNAs were used.  In brief, snRNP proteins were iso- 
lated by incubation of 10 nag immunoaliinity purified U snRNPs with 30 
ml DEAE cellulose (DE53; Whatman Laboratory Products Inc., Clinton, 
NJ) in buffer containing 150 mM KOAc, 140 mM NaCI, 5 rnM EDTA, and 
0.5 mM DTE. After incubation for 15 min on ice and a further 15 rain at 
37°C the DEAE-cellulose was pelleted by centrifugation.  The supernatunt 
contained the snRNP proteins. The solution was dialyzed  against buffer 
containing 20 mM Hepes-KOH,  pH 7.9, 50 mM KCI, 5 mM MgC12, and 
0.5 mM DTE. The native U snRNP proteins were concentrated using a Cen- 
triprep concentrator3 (Amicon Corp., Arlington Heights,  IL) in the first 
concentration step and Centricon C3 (Amicon Corp.) in the second to ob- 
tain snRNP proteins in concentrations up to 5 mg/mi. The yield was typi- 
caUy 1 mg native proteins from 10 nag U snRNP-particles.  In vitro reconsti- 
tution was carried out by incubation of 0.5 ~g (,x,9 pmol) U snRNA with 
5 ~g snRNP proteins in 3 ~tl reconstitution buffer for 30 rain at 30*(2 and 
15 min at 37°C. The in vitro reconstituted U snRNP particles were microin- 
jected without further purification. 
Cells and Microinjection 
Vero (African  green  monkey kidney)  and 3T3 cells  were grown in Dul- 
becco's modified Eagle  medium (GIBCO BRL, Bethesda,  MD)  sup- 
plemented  with  10% fetal  calf  serum,  5% CO2 at  37°C.  Xenopus A6  cells 
were grown in  L19 medium (GIBCO BRL) supplemented  with I0% fetal 
calf serum, 5% CO2 at 26°C.  For microinjection experiments Veto, A6, 
and 31"3 cells were plated on glass coverslips in 35 mm dishes with 3 mi 
medium and grown to 80% confluence.  Microinjection was carried out as 
described by Graessmann et ai. (1980) using an Eppendorf micromauipula- 
tor 5170 and microinjector 5242 and Eppendoff Femrotips. 
The amount of RNA injected in a typical experiment varied between 1-5 
×  105 molecules per cell. The injection volume was ,~200 fl per cell. 
Immunofluorescence 
Cells were prepared for immunofluorescence  by flooding the coverslips with 
ice-cold  3% paraformaldehyde  dissolved in PBS (pH 7.4) for 15 rain and 
permeabilized in 0.2 % Triton X-100 in PBS, pH 7.4, for 10 rain. Cells were 
blocked in 10% fetal calf serum in PBS, pH 7.4, for 1 h at room temperature 
and incubated with an anti-digoxygenin antibody (5 mg/ml) (Bochringer 
Mannheim Biochemicals,  Indianapolis,  IN) for 1 h. The cells were in- 
cubated for 30 rnin with an FITC-labeled  anti-mouse IgG (Amersham 
Corp.). 
Stained  ceils were mounted in mounting medium (Flunroprep; Bio- 
Merienx, France) and photographs were taken on a Leitz Axioplan micro- 
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fixed and analyzed directly. 
Fluorescence intensities in the nuclear and cytoplasmic fractions of fixed 
microinjected  Vero cells were determined using a digitalized computer sys- 
tem.  Nucleo-cytoplasmic ratios were calculated by dividing the fluores- 
cence intensity of the nuclear and cytoplasmic compartment. 
Results 
Nuclear Import of U1 snRNAs to the Nucleus Is 
a Temperature-dependent  Process Which Requires 
Binding of the Common Proteins to the RNA 
We recently reported that the transport of RNA in somatic 
cells could be investigated by immunofluorescent micros- 
copy after microinjection of in vitro transcribed RNA mole- 
cules labeled with digoxygenin (van Zee et al.,  1993). This 
procedure has been implemented in the present study to ana- 
lyze the signal requirements of U  snRNA transport in so- 
matic cells of diverse species. 
Using Vero (African green monkey kidney) cells we ini- 
tially analyzed the extent of nuclear import of m3G-capped 
digoxygenin-U1 RNA 3  h  after its microinjection into the 
cytoplasm.  As  shown in  Fig.  1 a,  m3G-capped U1  RNA 
was transported efficiently to the nucleus. The U1 RNA de- 
tected in the nucleus was localized primarily in the nucleo- 
plasm and excluded from the nucleoli. In cells which had 
received smaller amounts of digoxygenin-U1 RNA, we ob- 
served a nuclear staining pattern characteristic of endoge- 
nous U1 snRNAs (Canno-Fonseca et al., 1991a,b). As a con- 
trol, we carried out the same experiment at 4°C instead of 
37°C. Under these conditions, the microinjected RNA was 
localized almost exclusively in the cytoplasm which makes 
the possibility unlikely that diffusion is responsible for the 
observed transport (Fig.  1 b). 
In X. laevis oocytes nuclear import of U1 RNA requires 
the prior assembly of the Sm core domain in the cytoplasm 
(Mattaj,  1988).  To investigate the contribution of the Sm 
core domain to U1 RNA import in somatic cells, we exam- 
ined the transport behavior of the U1  RNA mutant desig- 
nated U1AD. The common Sm proteins fail to bind to U1AD 
due to a substitution in the Sm site (Mattaj and DeRobertis, 
1985; Mattaj, 1986). AS shown in Fig. 1, c and d, U1AD was 
almost completely excluded from the nucleus 3 h  after in- 
jection  into  the  cytoplasm,  irrespective  of the  nature  of 
the  Y-terminal  cap  structure,  as  neither ApppG-  (c)  nor 
m3GpppG-capped transcripts  (d)  were transported to  the 
nucleus. Further support for the hypothesis that binding of 
the Sm proteins plays a major role in nuclear targeting of U1 
RNA was provided by the following experiment. Co-injec- 
tion of the monoclonal anti-Sm antibody Y12-which reacts 
with the common proteins B, B', and D (Lerner and Steitz, 
1981)-with U1  RNA drastically inhibited the transport of 
U1  RNA (Fig 1 e). Antibody C383,  which reacts with the 
ribosomal protein S1 but not with snRNPs,  in contrast did 
not inhibit transport of U1 RNA (Fig.  1 f). The most likely 
explanation for this result is that the antibody Y12 either in- 
hibits the assembly of the common proteins on the U1 RNA 
molecule or binds to the in situ assembled U1 snRNP parti- 
cle directly and masks the signals required for import. In ei- 
ther case, this finding strongly indicates that the assembly of 
the Sm core domain in the cytoplasm is a necessary event 
Figure L Digoxygenin-labeled  U1 RNA transport to the nucleus of 
Vero cells depends on the assembly of the Sin proteins. Vero cells 
were  microinjected  with  digoxygenin-labeled m3GpppG-capped 
UI RNA (a and b), or a mutant lacking the Sm site (U1AD) and 
carrying either an ApppG- (c), or an m3GpppG-cap  (d). In Fig. 1, 
e and f, digoxygenin-labeled  m3GpppG-capped  U1 RNA was coin- 
jected with the monoclonal antibody Y12, which recognizes the 
common proteins B, B', and D1 or with the antibody C383 directed 
against the ribosomal protein S1 respectively. Every cell received 
an injection of ~1-5 x  105 RNA molecules. Ceils were incubated 
for 3 h at 37°C (a, c-e) or 4°C (b) and then fixed and stained with 
anti-digoxygenin-antibody and FITC conjugated anti-mouse anti- 
body. Bar, 10 #m. 
in targeting the U1  snRNP particle to the nucleus in Vero 
cells. 
We have recently shown that U1 snRNPs reconstituted in 
vitro from U1 RNA and native snRNP proteins were bona 
fide  substrates  for the  nuclear  transport  apparatus  of X. 
/aev/s oocytes (Fischer et al.,  1993).  The in vitro recon- 
stituted U1 snRNP particles used for these studies contained 
all the Sm proteins and  substoichiometric amounts of U1- 
specific proteins. For nuclear transport studies these parti- 
Fischer et al. Nucleo-cytoplasmic Transport of U snRNPs in Somatic Cells  973 cles offer a major advantage, in that the structural require- 
ments of U snRNPs for transport can be determined in the 
absence of the in situ assembly requirements. Thus, we im- 
proved the in vitro re,  constitution conditions for U1 snRNP 
to obtain digoxygenin-labeled U1  snRNPs sufficiently con- 
centrated for microinjection studies in somatic cells. When 
in  vitro  reconstituted  U1  snRNPs  containing  an  mTG  - 
capped digoxygenin-labeled U1 RNA were injected into the 
cytoplasm of Vero cells, they were targeted efficiently to the 
nucleus within 3 h,  demonstrating that they were efficient 
substrates for the nuclear transport apparatus (Fig. 2 a). 
Biochemical studies in the oocyte system have previously 
Figure 2.  Nuclear transport  of digoxygenin-labeled U1  snRNPs 
reconstituted in vitro. (A) Digoxygenin-labeled m3GpppG-capped 
U1  RNA molecules were reconstituted in vitro  as described  in 
Materials and Methods and injected without further purification 
into the cytoplasm of Vero cells (1  x  105 RNA molecules/ceU). 
Cells were incubated for 3 h at 37°C (a) or 4°C (b) and then stained 
with anti-digoxygenin- and FITC-conjugated anti-mouse antibody. 
(B) Comparison of the nuclear transport kinetics of U1 RNA and 
LI1 snRNPs rei:onstituted in vitro. Cells were microinjected with 
digoxygen!n-labeled m3GpppG capped  U1  RNA  (f-h)  and  U1 
snRNPs reconstituted in vitro (c-e) and incubated for 15, 30, and 
60 rain (c-e) or 30, 60, and 180 min (f-h) before being fixed and 
processed  for  immunofluorescence  as  described  above. Bar, 
10 #m. 
shown that the reconstituted U1 snRNPs were transported as 
such and that disassembly/reassembly processes were un- 
likely to occur under these conditions (Fischer et al., 1993). 
While similar biochemical studies were not feasible with so- 
matic  cells,  the following experimental evidence suggests 
that the in vitro reconstituted U1 snRNPs remained intact af- 
ter injection into somatic cells. When we compared the ki- 
netics of transport of U1 RNA microinjected either as naked 
RNA or as U1 snRNP reconstituted in vitro it became appar- 
ent that the reconstituted U1  snRNP particle was targeted 
more efficiently to the nucleus (Fig. 2 B). While the free U1 
RNA needed at least 3 h for complete nuclear accumulation 
(Fig. 2, f-h), the U1 snRNP particle was already transported 
to a  comparable extent after 1 h  (Fig.  2,  c-e).  The most 
likely explanation for this observation is  that the in vitro 
reconstituted U1 snRNP particle was transported as such to 
the nucleus. Further support for this notion that reconstituted 
snRNPs are transported as intact particles to the nucleus is 
presented below. 
Transport of U1 snRNPs Is a Mediated and Saturable 
Process in Somatic Cells 
Having  shown that U1  snRNPs  reconstituted in  vitro can 
serve as karyophiles in somatic cells, we were now able to 
analyze the nuclear targeting requirements for U1  snRNP 
particles  in  more  detail.  Initially,  we  asked  whether the 
transport of in vitro reconstituted U1 snRNP is a mediated 
process and can therefore be inhibited at 4°C.  It was only 
possible to carry out this experiment by using U1  snRNP 
particles reconstituted in vitro, since the binding of proteins 
to injected U1  RNA in oocytes is greatly reduced at 4°C 
(Fischer,  U.,  unpublished  observation),  m3G-capped  U1 
snRNP reconstituted in vitro was injected into the cytoplasm 
of Vero cells. After incubation for 3 h at 4°C, the cells were 
fixed and the subcellular distribution of U1 snRNP was ana- 
lyzed by immunofluorescence. As shown in Fig. 2 b, the in- 
jected particle remained almost entirely in the cytoplasm un- 
der these  conditions.  This  inhibition was  fully reversible 
within  1  h  after elevating  the  temperature  to  37°C  (not 
shown)  demonstrating  that  the  transport  process  of  U1 
snRNP in Vero cells is mediated and not due to diffusion. 
The next question we asked was whether the U1  snRNP 
transport is a saturable process. This would give an indica- 
tion for a  limiting transport factor which binds to the U1 
snRNP particle. For this purpose, we attempted to repress 
the nuclear transport of the digoxygenin-labeled U1 snRNPs 
by competition with nonlabeled U1 snRNPs. The latter had 
been purified from HeLa nuclear extracts and concentrated 
by MonoQ chromatography and ultracentrifugation to about 
20 mg/ml;  these and the labeled in vitro reconstituted U1 
snRNPs were co-injected into Vero cells. The rationale be- 
hind this experiment was that if the cell's capacity to trans- 
port U1 snRNP is limited, then the transport of the labeled 
particles should be reduced by saturation of the transport ap- 
paratus. In the presence of  a 20-fold molar excess of competi- 
tor U1  snRNP  (,02/~M  U1  snRNP/cell), the transport of 
digoxygenin-U1 snRNP reaches after 30 min an N/C value 
of ,01.1 (ratio of nuclear to cytoplasmic digoxygenin-labeled 
concentration,  as determined by quantitative fluorescence 
measurement), that is, the concentrations in the nuclear and 
cytoplasmic fraction were nearly the same (Fig. 3 A, c). In 
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a saturable process and does not interfere with the transport of 
karyophilic  proteins.  (A)  1  #M  solution  of m3GpppG-capped 
digoxygenin-labeled U1 snRNPs reconstituted in vitro was microin- 
jected either alone (a and b) or along with 20 #M of unlabeled 
affinity-purified U1 snRNP particles (c and d) into the cytoplasm 
of Veto cells. After an incubation of 30 (a and c) or 60 (b and d) 
minutes at 37°C the ceils were fixed and stained for immunofluores- 
cence as described  in Fig.  1.  (B) FITC-labeled BSA conjugated 
with NLS-sequences (1  #M) was injected into the cytoplasm of 
Vero cells either alone (a) or along with 20 t~M unlabeled affinity- 
purified U1 snRNP particles (b). Ceils were incubated for 30 rain 
at 37°C before they were analyzed by fluorescent microscopy. Bar, 
10 #m. 
contrast,  when  ceils  were  injected  with  digoxygenin-U1 
snRNP alone, the N/C ratio was 2.5 after the same incuba- 
tion time (Fig. 3 A, a). As expected, the difference  was found 
to level off if incubation was prolonged (Fig. 3 A, compare 
b and d) and was smaller if lower amounts of competitor U1 
snRNPs were used (not shown). This clearly demonstrates 
that the transport of U1 snRNP is a mediated process and that 
U snRNP transport factors in Vero cells are present in limit- 
ing amounts. 
The transport saturation observed in Fig. 3 A appears to 
be snRNP specific: a karyophilic protein such as FLUOS- 
labeled BSA conjugated with 8-10 NLS sequences from SV- 
40 T-antigen (BSA-NLS) is also transported to the nucleus 
in the presence of an excess of non-labeled U1 snRNP (the 
same amount of competitor U1  snRNP was co-injected as 
used for competition with the labeled U1  snRNP).  Neither 
the kinetics nor the final extent of nuclear accumulation was 
affected (Fig. 3 B, a  and b, and data not shown). The same 
observation was made when a karyophilic protein carrying 
only one NLS  (P4,  ~galactosidase  fused with the SV-40 
T-antigen NLS [Rhis and Peters, 1989]) was used (data not 
shown). Thus our data indicate that, in somatic cells as in 
X.  /aev/s  oocytes,  distinct  transport  factors  mediate  the 
transport of U1  snRNP and karyophilic proteins. 
The mjG-cap Contributes to the Nuclear Uptake of 
U1 snRNP Even Though It Has No Essential Signaling 
Function in Somatic Cells 
Having established that the U1 snRNP transport in somatic 
cells is a temperature-dependent and -mediated process, we 
investigated in more detail the nuclear import signal require- 
ments of the U1 snRNP particle, in particular the role of the 
m3G-cap. 
In  vitro  reconstituted  U1  snRNPs  containing  ApppG- 
capped U1  RNA were injected into the cytoplasm of Vero 
cells and incubated for 3 h. Surprisingly, the particle was tar- 
geted to the nucleus to an extent comparable to that of U1 
snRNPs with the m3GpppG-cap (Fig. 4 A, a  and b).  This 
result indicated that in contrast to the situation in oocytes, 
the m3G-cap is not essential for the nuclear uptake of U1 
snRNP in Vero cells.  As expected, nuclear import of both 
m3GpppG- and ApppG-capped U1  snRNPs was blocked if 
injected cells were incubated at 4°C instead of 37°C (Fig. 4 
A,  c  and  d).  In  agreement  with  the  above findings,  co- 
injection of a  10 mM solution of isolated m3GpppG cap did 
not inhibit the transport of U1 RNA after 3 h (Fig. 4 A, e). 
The same amount of m3GpppG-cap would inhibit the trans- 
port of U1 snRNP in oocytes completely (Fischer and Liihr- 
mann,  1990). 
Although  the m3G-cap is  not essential  for nuclear  im- 
port, it does enhance the transport kinetics of U1 snRNPs. 
In a comparison of the transport kinetics of m3GpppG- and 
ApppG-capped in vitro reconstituted U1  snRNPs,  ApppG- 
capped particles showed significantly slower transport ki- 
netics than those bearing an m3GpppG-cap (Fig. 4 B). Af- 
ter  15  min the m3GpppG-capped U1  snRNPs  reached an 
N/C ratio of approximately 1 (row a). The same accumula- 
tion of ApppG-capped U1  snRNP  was  not observed until 
45-60 min after injection (row b).  After 3 h, however, no 
(or only marginal) differences in the N/C ratios of the differ- 
ent particles were observed. 
We next wished to know whether the differences in the 
m3G-cap  requirement  for  nuclear  transport  of  U1  RNA 
were also observable in human 3"1"3 and Xenopus A6 cells. 
This would give an indication of whether the differences in 
the  signal  requirement  of  U1  snRNP  is  cell  or  species 
specific. We injected in vitro reconstituted U1 snRNPs car- 
rying either an ApppG- or an m3GpppG-cap into 3T3 and 
A6 cells and analyzed the nuclear transport as described for 
Vero cells.  As shown in Fig.  4  C the U1  snRNP-particles 
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quired for nuclear targeting but accelerates the transport kinetics 
in Vero 3T3, and A6 cells. (A) ApppG-capped 131 snRNPs recon- 
stituted in vitro are transported actively  to the nucleus of Vero cells. 
In vitro transcribed digoxygenin-labeled  U1 RNA molecules carry- 
ing either an maGpppG-cap (a and c) or the synthetic ApppG-cap 
(b and d) were reconstituted  in vitro and injected into the cytoplasm 
of Vero cells ("~1  x  105 RNP particles/cell). In e the m3GpppG- 
capped U1  snRNP  was coinjected with  10  mM free m3GpppG- 
cap. Cells were incubated for 3  h  at either 37°C  (a, b,  and e) 
or 4°C  (c and d), fixed, and then processed for immunofluores- 
cence.  (B) Comparison of the transport kinetics of ApppG- and 
m3GpppG-capped U1 snRNP-particles in Vero cells. Digoxygenin- 
labeled U1 snRNP particles reconstituted in vitro carrying either 
an m3GpppG- (row a) or an ApppG-cap (row b) were injected 
into the cytoplasm of Vero cells and incubated at 37°C for 15, 30, 
and 60 min, respectively, fixed, and processed for immunofluores- 
cence. (C) Nuclear transport of m3GpppG-and ApppG-capped U1 
snRNPs in mouse 3T3 and Xenopus A6 cells. Digoxygenin-labeled 
U1 snRNPs reconstituted in vitro carrying either an m3GpppG- (a 
and c) or an ApppG-cap (b and d) were injected into the cytoplasm 
of either 3T3 cells (a and b) or A6 cells (c and d) and incubated 
at 37°C for 60 min. Cells were hereafter fixed and processed for 
immunofluorescence. Bar,  10/zm. 
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similar  to  that  observed  in  Vero  cells:  both  m3GpppG- 
capped and ApppG-capped U1 snRNPs were targeted to the 
nucleus,  however  the  ApppG-capped  particle  was  sig- 
nificantly less efficiently transported (Fig. 4 C, a and b). A 
similar situation was also observed when we analyzed the 
nuclear transport of U1 snRNP in A6 cells. Again, both the 
m3GpppG and the ApppG capped particles were targeted to 
the nucleus but the latter significantly slower (Fig. 4 C, c and 
d). We note that in A6 cells the kinetics of the nuclear ac- 
cumulation of U1 snRNPs in general was much slower, when 
compared to Vero and 3T3 cells.  A  substantial amount of 
m3GpppG-capped  U1  snRNP  was  still  detectable  in  the 
cytoplasm after 4 h, while in Vero and 3T3 cells essentially 
all of the injected particles accumulate in the nucleus after 
only 1 h (compare Fig. 4  C, c with Fig. 2 B). In sum, our 
data show that the nuclear transport of U1 snRNP in Vero, 
3T3, and A3 cells appears to be less strictly dependent on 
the presence of the m3G-cap than in oocytes. However, the 
m3G-cap does accelerate the transport kinetics of U1 snRNP 
indicating that it has retained a signaling role for nuclear tar- 
geting of U1  snRNPs in somatic cells. Moreover, our data 
strongly suggest that cell specific rather than species specific 
differences account  for the  differential  m3G-cap  require- 
ment in nuclear import of U1  snRNPs. 
One possible explanation for the differential requirement 
for the m3G-cap in  U1  snRNP  transport in  somatic cells 
versus X./aev/s oocytes could be due, at least in part, to the 
differential contribution of U1  specific proteins to nuclear 
transport in the two cell systems. Given that some of the U1 
specific proteins also contain NLSs (Kambach and Mattaj, 
1991; Jantsch and Gall, 1991), one could envisage the possi- 
bility that in somatic cells these signals might override the 
m3G-cap signal and therefore obviate the need for the cap 
in U1 snRNP transport. To address this question we analyzed 
the transport of an artificial RNA that contained the 3'-ter- 
minal 42 nucleotides of U1 RNA (encompassing the Sm site 
and  stern/loop E)  and  an artificially designed 5' terminal 
stem/loop  structure  22-nucleotides  long  (Fischer  et  al., 
1993). This RNA designated as SmlI RNA, can bind only 
the  common but not the  specific U  snRNP  proteins  and 
therefore enabled us to analyze the contribution of the Sm 
core domain in nuclear targeting, while any contribution of 
the UI  specific proteins can be excluded. 
We have previously observed that injection of naked SmlI 
RNA in oocytes yielded transport deficient SmlI RNP parti- 
cles in the ooplasm. Moreover, immunoprecipitation experi- 
ments revealed that the in vivo assembly of SmlI RNP in oo- 
cytes was less efficient as compared to U1 RNA (Fischer et 
al.,  1993).  It was therefore not surprising that no nuclear 
transport was observed either when naked SmlI RNA was in- 
jected into  Vero  cells.  In  fact,  cells  injected with  naked 
digoxygenin-labeled SmII RNA could not be stained by im- 
munofluorescence,  suggesting  that  this  RNA  is  rapidly 
degraded in situ (not shown). In contrast, in vitro prepared 
SmII snRNPs proved to be more stable and could be detected 
by immunofluorescence, consistent with our observation that 
in vitro reconstituted SmlI RNPs are also efficiently trans- 
ported in Xenopus oocytes (Fischer et al.,  1993). In the fol- 
lowing transport experiments, we therefore used exclusively 
the SmlI snRNP particle prepared in vitro. As shown in Fig. 
5  A  (a)  the  in  vitro  prepared  m3GPpppG-capped  SmlI 
Figure 5. A minimal SmH RNA which binds exclusively the com- 
mon proteins is targeted to the nucleus after reconstitution in vitro. 
(A) In vitro transcribed digoxygenin-labeled  SmII RNA carrying an 
m3GpppG-cap was injected after reconstitution in vitro into the 
cytoplasm of Vero ceils (a and c). Cells shown in b and d were in- 
jected with in vitro reconstituted ApppG-capped SmIl RNP. Cells 
were incubated for 1 h at 37"C (a and b) or 4"C (c and d) before 
they were fixed and processed for immunofluorescence. (B) Satura- 
tion of SmlI snRNP transport by co-injection of excess isolated U1 
snRNP.  A  1-#M solution  of m3G-capped digoxygenin-labeled 
SmII snRNP reconstituted in vitro was injected either alone (a and 
c) or along with 20 #M of unlabeled U1 snRNP into the cytoplasm 
of Vero cells (b and d). After 30 (a and b) and 120 rnin (c and d) 
cells were fixed and analyzed by immunofluorescence. Bar, 10 #m. 
snRNP  was  as efficiently transported to the nucleus as in 
vitro reconstituted U1 snRNPs after 1 h. This transport also 
occurred independently of  the cap structure of  the SmlI RNA 
as ApppG- and m3GpppG-capped SmII snRNPs were both 
transported to the nucleus to a comparable extent within 1 h 
(Fig. 5 A, b). To exclude any uptake due to passive diffusion, 
we incubated Vero cells injected with SmII snRNP at 4°C 
and analyzed the transport 1 h later. As expected, the trans- 
port was severely inhibited excluding diffusion of the SmlI 
snRNP into the nucleus (Fig. 5 A, c and d). In addition the 
transport of SmII snRNP was also inhibited to a significant 
extent by co-injection of an excess of unlabeled U1  snRNP 
(Fig.  5  B, compare a  and c  with b  and d).  These results 
resembled strongly the saturation of digoxygenin-labeled U1 
snRNP transport shown in Fig.  3 in that the same amount 
of competitor U1 snRNP was needed to obtain a comparable 
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snRNP in an import reaction it is likely that both the U1 
snRNP and the SmII snRNP bind the same limiting transport 
factor(s) and therefore use the same pathway to migrate into 
the nucleus. Moreover these results rule out any contribution 
of the U1 specific proteins of the U1 snRNP particle to nu- 
clear targeting. Taken together, our data suggest that the Sm 
core domain is not only an essential signalling structure but 
under certain conditions, is also sufficient to bring about nu- 
clear transport of U1  snRNP particle in Vero ceils. 
Discussion 
In this report we have used microinjection of digoxygenin- 
labeled U1 RNA and snRNP and derivatives thereof to study 
the structural requirements of snRNA transport in somatic 
cells. 
Several lines of experimental evidence indicate that the 
transport of digoxygenin-labeled snRNAs was  specific and 
not due to possible diffusion of breakdown products and/or 
to nonspecific association with cellular structures: (a) When 
free U1  RNA molecules were injected into the cytoplasm 
they accumulated  in  the  nucleoplasm only excluding the 
nucleoli. Moreover transport was observed only at 37°C but 
not at 4°C. These facts do not agree with the possibility that 
breakdown products of U1 RNA have accumulated in the nu- 
cleus in an unspecific way. (b) Transport of free U1 RNA is 
dependent on the assembly of Sm proteins as shown by the 
failure  of U1AD  to  be  transported  and  the  finding  that 
anti-Sm antibody Y12 strongly interferes with nuclear trans- 
port. Again this would not be expected if only fragments of 
degraded RNAS diffuse to the nucleus. (c) When free SmII 
RNA was injected this RNA was apparently not assembled 
in situ into a stable SmlI complex and therefore degraded in 
the cell. Remarkably under these conditions no fluorescent 
label was detectable after 1-3-h incubation, neither in the 
cytoplasm  nor  in  the  nucleus.  This  also  shows  that  if 
digoxygenin-labeled RNAs are degraded the digoxygenin- 
labeled nucleotides apparently are not efficiently incorpo- 
rated in situ into newly transported endogenous RNA mole- 
cules. Frequently we observed that a small fraction of the 
injected digoxygenin-labeled RNA  remained  in  the  cyto- 
plasm in separate dots. It is currently not clear whether this 
is due to either aggregation of the digoxygenin-labeled RNA 
with other cellular structures or precipitation of a fraction 
of the injected material in the cytoplasm. 
A major breakthrough in our studies was the possibility to 
obtain in vitro reconstituted digoxygenin-labeled snRNPs at 
concentrations allowing microinjection into somatic cells. 
This enabled us to study the structural requirements for the 
transport of U1 snRNPs independently of the in situ assem- 
bly of snRNPs. We have good reasons to believe that the in 
vitro reconstituted snRNPs are transported in Vero cells as 
such and do not undergo a disassembly/reassembly process. 
First,  the  kinetics  of  nuclear  transport  of reconstituted 
snRNPs are faster as compared with injected free snRNA. 
Second, only the reconstituted SmII snRNP was stable in the 
cell and targeted actively to the nucleus whereas the free 
RNA was degraded (see above). 
As in oocytes, the transport of U1 snRNP and SmlI snRNP 
in  somatic cells was  strongly temperature dependent and 
saturable (Figs. 2 and 3) indicating an active and mediated 
process. 
As shown in oocytes, U snRNPs, and karyophilic proteins 
use different kinetic pathways to reach the nucleus. This con- 
clusion could be drawn by the observation that upon satura- 
tion of the protein transport the U  snRNP transport could 
proceed and vice versa (Fischer et al.,  1993; Michand and 
Goldfarb,  1991,  1992).  As  shown in this report the same 
holds true also for Vero cells: when the 121 snRNP transport 
was saturated by injection of an excess of  purified U1 snRNP 
the protein transport was not affected at all. This observation 
fits nicely with the recent finding that the expression of a 
frameshift mutant of the large T-antigen of SV-40 in Vero 
cells inhibits the transport of heterologous karyophilic pro- 
teins but not of U1 RNA (van Zee et al.,  1993). In this case 
strong evidence has been presented that the T-antigen mutant 
titrates out a limiting protein specific transport factor while 
the U snRNP-specific transport pathway is unaffected. Fur- 
thermore, transport competition studies carded out in vitro 
along the same lines as described in this work are fully con- 
sistent with the above stated conclusions (Marshallsay and 
Liihrmann,  1984). 
In X.  /aev/s  oocytes the  spliceosomal  snRNAs  have a 
differential  m3G-cap  requirement  for  nuclear  transport: 
whereas U1  and U2 transport is strictly dependent on the 
5'-terminal m3G-cap,  U4 and U5 snRNAs can enter the nu- 
cleus  also  with  an  unphysiological  ApppG-cap  at  their 
5'-ends (Fischer et al.,  1991).  One of the most surprising 
findings in this work was that the m3G-cap of U1 snRNP is 
not an essential signaling component in somatic cells. It ap- 
pears that this is also true for the other spliceosomal snRNPs 
since U5  was  also transported m3G-cap independently to 
the nucleus in Vero cells (not shown). However, the m3G-cap 
still has retained a signaling role for the nuclear targeting of 
U1  snRNP,  since ApppG-capped U1  snRNPs  showed sig- 
nificantly slower transport kinetics than m3GpppG-capped 
one. Since this feature was observed in somatic cells from 
different species (Xenopus A6, mouse 3T3 and monkey Vero 
cells) we propose that it may apply more generally for so- 
matic cells and is not species specific. 
While the m3G-cap is not strictly required, the Sm core 
domain in contrast might even be sufficient for nuclear tar- 
geting of U1 snRNP in somatic cells. This is underscored by 
the finding that: (a) U1 RNA but not U1AD is targeted to the 
nucleus; (b) the SmII RNP reconstituted in vitro migrates to 
the nucleus independently whether the RNA contained an 
ApppG- or an m3GpppG-cap; and (c) the transport of SmII 
RNP was inhibited upon coinjection of saturating amounts 
of U1 snRNP. The Sm core domain facilitates therefore the 
nuclear transport of U1 snRNP by interaction with a limiting 
factor. 
Why does the U1  snRNP require the m3G-cap as an es- 
sential part of the NLS in oocytes but not in Vero, A6, and 
3T3 ceils? Structural variations of components of the trans- 
port apparatus in the different cell types is one possible ex- 
planation for these observations. Similarly, differences in the 
cellular factors in oocytes and somatic cells could also be the 
reason for the differential m3G-cap requirement in nuclear 
transport of U1 snRNP.  Because the Sm core domain is es- 
sential for nuclear targeting of U1 snRNP not only in somatic 
cells but also in the oocyte, it appears likely that differences 
in  the  recognition  of this  domain  by  a  transport  factor 
account  for  the  m3G-cap  dependence.  According  to  this 
model a Sm core domain recognizing transport factor which 
differs from its oocyte equivalent is present in A6 ceils (and 
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to possess a higher "transport activity" which makes the cap 
less important.  The higher "activity" of this factor could re- 
sult from differences in posttranslational  modification or in 
genetic variation.  The oocyte receptor equivalent might have 
a lower nuclear targeting  activity and makes the assistance 
of the m3G-cap essential. 
One prediction of the above mentioned model is that the 
m3G-cap  requirement  for  nuclear  import  changes  during 
development of the oocyte to somatic cells. It is currently not 
yet clear at which stage in the development the switch in the 
signal requirement occurs nor it is known whether this pro- 
cess affects events in development. Interestingly,  a compari- 
son to the nuclear transport  of karyophilic proteins reveals 
that  several cases of cell type-  and species-specific differ- 
ences in the usage of NLS exist (Slaviak et al.,  1989;  Stan- 
diford  and  Richter,  1992;  Fischer-Fantuzzi  and  Vesco, 
1988).  For example a developmentally regulated NLS was 
recently discovered in the E1A protein of adenovirus 5 (Stan- 
diford and Richter,  1992).  This NLS functions in Xenopus 
oocytes and in cells of the embryo up to the early neurular 
stage but not later in development or in A6 cells. Therefore, 
the same situation we have observed for the transport of U1 
snRNPs  in  different  cell  types  may  apply  also  for  some 
karyophilic proteins. 
The NLS of U1 snRNP, although structurally  completely 
different probably  resembles in its  modular character,  the 
bipartite NLS of karyophilic proteins (Dingwall and Laskey, 
1991).  The downstream cluster of protein NLS might have 
its  equivalent  in the  Sm  core domain  and is  likely  to be 
responsible for efficient binding to the transport factors. The 
m3G-cap in contrast (similar to the upstream cluster in pro- 
tein  NLS)  might have  rather  a  degenerative  function and 
might be dispensable when cellular conditions or the snRNP 
structure  allows this. 
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